CaMKII is activated during cardiac hypertrophy, and inhibition of CaMKII profoundly alleviates myocardial hypertrophy, cardiomyopathy, and heart failure (22, 62, 63). This evidence concerns the gene CAMK2G and cardiomyopathy.